BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of marker genes starting with is 35
| GENE | HGNC_ID | CANCER_TYPE | HISTOLOGICAL_TYPE | CSC_ENRICHMENT | METHOD | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|
| BMI1 | 1066 | Bladder Cancer | NA | NA | IHC staining followed by qRT-PCR and Western Blotting | 0.96 | 0.1135 | 26489630 |
| BMI1 | 1066 | Bladder Cancer | Carcinoma | NA | IHC staining | 0.96 | 0.1135 | 22343321 |
| POU5F1 | 9221 | Bladder Cancer | NA | NA | RT-PCR and IHC staining | 0.6 | 0.6448 | 17205510 |
| POU5F1 | 9221 | Bladder Cancer | NA | NA | SFA followed by IF staining | 0.6 | 0.6448 | 19961489 |
| SUV39H1 | 11479 | Bladder Cancer | NA | NA | SFA followed by Transcriptomics and qRT-PCR | 0.4 | 0.0011 | 28765327 |
| ALCAM | 400 | Bladder Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0583 | 32424373 |
| ALDH1A1 | 402 | Bladder Cancer | NA | NA | IHC staining | 0.32 | 0.684 | 34101386 |
| ALDH1A1 | 402 | Bladder Cancer | NA | NA | IHC staining | 0.32 | 0.684 | 20142235 |
| ALDH1A1 | 402 | Bladder Cancer | NA | NA | IHC staining | 0.32 | 0.684 | 25843691 |
| ALDH1A1 | 402 | Bladder Cancer | NA | NA | FACs followed by SFA | 0.32 | 0.684 | 32019566 |
| CD24 | 1645 | Bladder Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.456 | 32424373 |
| CD44 | 1681 | Bladder Cancer | NA | NA | IHC staining | 0.32 | 1 | 34101386 |
| CD44 | 1681 | Bladder Cancer | NA | NA | IHC staining | 0.32 | 1 | 20142235 |
| CD44 | 1681 | Bladder Cancer | NA | NA | IHC staining | 0.32 | 1 | 28607587 |
| CD44 | 1681 | Bladder Cancer | Carcinoma | NA | IHC staining | 0.32 | 1 | 30128900 |
| CD44 | 1681 | Bladder Cancer | NA | NA | IHC staining | 0.32 | 1 | 31718471 |
| CD44 | 1681 | Bladder Cancer | Carcinoma | NA | IHC staining | 0.32 | 1 | 32424373 |
| CD44 | 1681 | Bladder Cancer | NA | NA | IHC staining followed by SP assay and CFA | 0.32 | 1 | 18608209 |
| CD44 | 1681 | Bladder Cancer | NA | NA | SFA followed by qRT-PCR | 0.32 | 1 | 28765327 |
| CD44 | 1681 | Bladder Cancer | NA | NA | FACs | 0.32 | 1 | 32065779 |
| CD44 | 1681 | Bladder Cancer | NA | NA | FACs followed by SFA | 0.32 | 1 | 26143634 |
| CD44 | 1681 | Bladder Cancer | NA | NA | FACs followed by SFA | 0.32 | 1 | 32019566 |
| CD44 | 1681 | Bladder Cancer | NA | NA | SFA followed by FACs | 0.32 | 1 | 28765327 |
| KLK10 | 6358 | Bladder Cancer | NA | NA | SFA followed by IF staining | 0.32 | 0.0032 | 19961489 |
| NANOG | 20857 | Bladder Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.5461 | 22343321 |
| NANOG | 20857 | Bladder Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.5461 | 32424373 |
| PROM1 | 9454 | Bladder Cancer | NA | NA | IHC staining | 0.32 | 0.7582 | 31718471 |
| PROM1 | 9454 | Bladder Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.7582 | 32424373 |
| PROM1 | 9454 | Bladder Cancer | NA | NA | SFA followed by IF staining | 0.32 | 0.7582 | 19961489 |
| GLI1 | 4317 | Bladder Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0308 | 28765327 |
| SOX2 | 11195 | Bladder Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.5695 | 28765327 |
| SOX2 | 11195 | Bladder Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.5695 | 32019566 |
| SOX2-OT | 20209 | Bladder Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0011 | 32019566 |
| STAT3 | 11364 | Bladder Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0223 | 28765327 |
| TDO2 | 11708 | Bladder Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.0011 | 34101386 |